logo

For the Inventor, By the Inventor

Yokohama, Japan

Koji Mitsugi

This inventor holds 12 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koji Mitsugi. Retrieved from https://idiyas.com/inventor/koji-mitsugi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 93(Granted Patents)


Location History:

  • Kanagawa, JA (1977)
  • Yokohama, JA (1976 - 1978)
  • Yokohama, JP (1980 - 1983)
  • Kanagawa, JP (1988)

Company Filing History:

goldMedal12 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1976-1988

Loading Chart...
12 patents (USPTO):Explore Patents
1. 4789658 - Immunoprophylactic and immunotherapeutic agents (1988-12-06),
2. 4371613 - Method for producing purine arabinosides (1983-02-01),
3. 4228241 - Method for producing a peptidase (1980-10-14),
4. 4211840 - Method for producing D-.alpha.-amino acid (1980-07-08),
5. 4184918 - Method for producing 4-formyl-2-amino-butyric acid (glutamic (1980-01-22),
6. 4072687 - Process for producing 2-amino-(2)-thiazoline-4-carboxylic acid (1978-02-07),
7. 4071405 - Method of producing sulfur containing L-amino acids (1978-01-31),
8. 4022666 - Alpha-amylases from Bacillus subtilis (1977-05-10),
9. 4016037 - Method for producing L-amino acid (1977-04-05),
10. 4006057 - Method of producing L-cysteine and L-cystine (1977-02-01),
11. 3957581 - Method of producing peptidase (1976-05-18),
12. 3930948 - Enzymatic method for producing aromatic ethylamines (1976-01-06),

Sure, I can assist you with that. Let's start crafting the article.

Title: The Innovative Work of Koji Mitsugi - Pioneering Inventor from Yokohama

Introduction: In the realm of innovation and patent advancements, Koji Mitsugi has emerged as a prominent figure, contributing significantly to the field of medical research and pharmaceuticals. Hailing from Yokohama, Japan, Mitsugi has made a name for himself with his groundbreaking inventions and patents.

Latest Patents:

1. Immunoprophylactic and immunotherapeutic agents: Mitsugi's latest patent involves the creation of an immunoprophylactic and immunotherapeutic agent incorporating human interleukin 2 of human cellular origin. The disclosed method for producing this agent showcases his dedication to advancements in healthcare.

2. Method for producing purine arabinosides: Mitsugi's patent details a method for producing purine-arabinosides, highlighting his expertise in biochemistry and enzymology. This innovative process involves the utilization of specific enzymes to facilitate the production of 9-(.beta.-D-arabinofuranosyl)-purine.

Career Highlights: With an impressive portfolio of 12 patents to his name, Koji Mitsugi has established himself as a pioneer in the world of biomedical research. His work reflects a deep understanding of pharmacology and bioengineering, paving the way for new treatment modalities and therapeutic interventions.

Collaborations: Mitsugi's collaborative efforts have further enhanced his contributions to the field. Working alongside esteemed colleagues such as Konosuke Sano and Kenzo Yokozeki at Ajinomoto Co., Ltd., Mitsugi has been able to synergize his ideas and expertise, leading to the development of cutting-edge pharmaceutical solutions.

Conclusion: In conclusion, Koji Mitsugi's journey as an inventor exemplifies dedication, passion, and a relentless pursuit of knowledge in the field of medical innovation. His patents stand as testaments to his ingenuity and commitment to advancing healthcare technologies, making him a revered figure in the realm of inventions and patents.

Is there anything else you would like to add or modify in the article?

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…